Bank of America
EXOZ

Bank of America’s eXoZymes Inc EXOZ Stock Holding History

Bank of America’s Portfolio EXOZ Stock Details EXOZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17
Closed -$185 – 7159
2025
Q4 		$185 Sell
17
-6
-26% -$83 ﹤0.01% 6714
2025
Q3 		$332 Sell
23
-13
-36% -$142 ﹤0.01% 7657
2025
Q2 		$356 Buy
36
+5
+16% +$61 ﹤0.01% 7727
2025
Q1 		$324 Buy
31
+16
+107% +$238 ﹤0.01% 7598
2024
Q4 		$248 Buy
+15
New +$222 ﹤0.01% 7547

Other funds holding EXOZ

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America's EXOZ Position: Q1 2026 in Review

Bank of America sold out of eXoZymes Inc (EXOZ) in Q1 2026, closing a stake of 17 shares — an estimated $185 sold.

Bank of America first reported a position in EXOZ in Q4 2024 and held it in 5 quarters. The position peaked at $356 in Q2 2025. 7 funds tracked by Wall St. Rank hold EXOZ as of Q1 2026.

  • Bank of America reported no remaining eXoZymes Inc position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 17 eXoZymes Inc shares in Q1 2026, an estimated $185.
  • Bank of America first reported a position in eXoZymes Inc in Q4 2024 and held it in 5 quarters.
  • Bank of America's eXoZymes Inc position peaked at $356 in Q2 2025.
  • 7 funds tracked by Wall St. Rank held eXoZymes Inc as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.